Overview
Alexei Arkhipov is a Hematologist Oncology specialist and a Hematologist in San Antonio, Texas. Dr. Arkhipov has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency. Dr. Arkhipov is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Texas Oncology PA
Christopher Braden is a Hematologist Oncology specialist and a Palliative Medicine provider in New Braunfels, Texas. Dr. Braden is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Small Lymphocytic Lymphoma (SLL), and Paget Disease of the Breast. Dr. Braden is currently accepting new patients.
Texas Oncology PA
Eswar Tipirneni is a Hematologist Oncology specialist and a Hematologist in San Antonio, Texas. Dr. Tipirneni is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma. Dr. Tipirneni is currently accepting new patients.
South Texas Oncology And Hematology, PLLC
Antoine Harb is a Hematologist Oncology specialist and a Hematologist in San Antonio, Texas. Dr. Harb is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Harb is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Congenital Antithrombin 3 DeficiencyDr. Arkhipov isAdvanced. Learn about Congenital Antithrombin 3 Deficiency.
- Deep Vein ThrombosisDr. Arkhipov isAdvanced. Learn about Deep Vein Thrombosis.
- Hereditary Resistance to Anti-Vitamin K
- Protein C DeficiencyDr. Arkhipov isAdvanced. Learn about Protein C Deficiency.
- Protein S DeficiencyDr. Arkhipov isAdvanced. Learn about Protein S Deficiency.
- Experienced
- AgranulocytosisDr. Arkhipov isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Arkhipov isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Blood ClotsDr. Arkhipov isExperienced. Learn about Blood Clots.
- Childhood Iron Deficiency AnemiaDr. Arkhipov isExperienced. Learn about Childhood Iron Deficiency Anemia.
- Chronic Familial NeutropeniaDr. Arkhipov isExperienced. Learn about Chronic Familial Neutropenia.
- Colorectal CancerDr. Arkhipov isExperienced. Learn about Colorectal Cancer.